[Prevention and immunotherapy of staphylococcal infections with bacterial vaccines].
Pathogenesis of staphylococcal infection both local and systemic is associated with many pathogenicity factors, which in foreign literature are called virulence factors of Staphylococcus aureus, which were studied as potential candidates for vaccine development. Much difficulties are related to use of known experimental models, which virtually do not allow to determine direct appropriate effect by survival of animals, as well as to data about absence of correlation between increase of antibody titers in animals and protective effect of studied preparations. Despite the importance of the problem of prevalence and severity of staphylococcal infection and intensive research in order to determine protective components able to protect from infection caused by S. aureus, there are no licensed prophylactic preparations with proven efficacy.
O M
OM
Kuz'menko
I M
IM
Gruber
R G
RG
Priiatkin
D000818:Animals; D000907:Antibodies, Bacterial / Q000097:blood; D014943:Global Health; D006801:Humans; D013203:Staphylococcal Infections / Q000097:blood / Q000517:prevention & control / Q000628:therapy*; D013209:Staphylococcal Vaccines / Q000276:immunology / Q000627:therapeutic use*; D013211:Staphylococcus aureus / Q000276:immunology* / Q000472:pathogenicity; D014611:Vaccination; D037521:Virulence Factors / Q000276:immunology*
D000907:Antibodies, Bacterial; D013209:Staphylococcal Vaccines; D037521:Virulence Factors